About Us

Internal Target Validation Committee

Master
Content

To help identify the most promising target candidates to bring into a drug discovery partnership, an Internal Target Validation Committee (ITVC) comprised of Baylor faculty has been established.

Heading

Chair

Terms
Salma

Item Term
Salma Kaochar, Ph.D., MFA

Item Definition

Assistant Professor, Medicine – Hematology & Oncology, Molecular & Cellular Biology, Dan L Duncan Comprehensive Cancer Center

Heading

Co-Chair

Terms
Damain

Item Term
Damain Young, Ph.D.

Item Definition

Associate Director, Center for Drug Discovery
Assistant Professor, Pharmacology & Chemical Biology and Pathology & Immunology
Blue Square Discoveries Scientific Business Development Director
 

Heading

Committee Members

Terms
Member

Item Term
Malcolm Brenner, M.D., Ph.D.

Item Definition

Professor, Center for Cell & Gene Therapy, Molecular & Human Genetics, Pediatrics, Medicine, Translational Biology & Molecular Medicine

David

Item Term
David Nelson, Ph.D.

Item Definition

Professor, Molecular & Human Genetics

Dr.

Item Term
Trey Westbrook, Ph.D.

Item Definition

Professor, Molecular & Human Genetics, Biochemistry & Molecular Biology
Director, Therapeutic Innovation Center (THINC)